1 |
100 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
2 |
200 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
3 |
400 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
4 |
4d-125 ivt injection |
- |
- |
- |
- |
090 1件: 90 💬 |
5 |
9715x |
- |
- |
- |
- |
090 1件: 90 💬 |
6 |
9741x |
- |
- |
- |
- |
090 1件: 90 💬 |
7 |
9742x |
- |
- |
- |
- |
090 1件: 90 💬 |
8 |
Aav-rpgr |
- |
- |
- |
- |
090 1件: 90 💬 |
9 |
Aav2-rep1 |
- |
- |
- |
- |
090 1件: 90 💬 |
10 |
Aav2/5-hpde6b |
- |
- |
- |
- |
090 1件: 90 💬 |
11 |
Aav2/5-hrkp.rpgr |
- |
- |
- |
- |
090 1件: 90 💬 |
12 |
Aav8-rpgr |
- |
- |
- |
- |
090 1件: 90 💬 |
13 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
14 |
Acetazolamide |
Acetazolamide |
2件: D00218 D00218, D01196 D01196 💬 |
CA1 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion 7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
013 6件: 13, 90, 115, 155, 225, 230 💬 |
15 |
Aflibercept |
Aflibercept |
1件: D09574 D09574 💬 |
PGF 3件: PGF, VEGFA, VEGFB 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
090 2件: 90, 166 💬 |
16 |
Alga dunaliella bardawil |
- |
- |
- |
- |
090 1件: 90 💬 |
17 |
Alga dunaliella bardawil powder |
- |
- |
- |
- |
090 1件: 90 💬 |
18 |
Alga dunaliella bardawill |
- |
- |
- |
- |
090 1件: 90 💬 |
19 |
Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded |
- |
- |
- |
- |
090 1件: 90 💬 |
20 |
Antioxidants |
- |
- |
- |
- |
090 3件: 90, 298, 310 💬 |
21 |
Betamethasone |
Betamethasone |
7件: D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 6件: 2 , 28, 46, 90, 96, 235 💬 |
22 |
Bmmncs |
- |
- |
- |
- |
090 1件: 90 💬 |
23 |
Brimonidine |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
24 |
Brimonidine tartrate |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
25 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
26 |
Bs01 |
- |
- |
- |
- |
090 1件: 90 💬 |
27 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
28 |
Carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
29 |
Cd34+ bone marrow stem cells intravitreal |
- |
- |
- |
- |
090 1件: 90 💬 |
30 |
Cholesterol |
Cholesterol |
1件: D00040 D00040 💬 |
- |
- |
019 6件: 19, 90, 160, 259, 261, 310 💬 |
31 |
Ciliary neurotrophic factor |
Ciliary neurotrophic factor |
- |
- |
- |
090 1件: 90 💬 |
32 |
Ciliary neurotrophic factor implant nt-501 |
Ciliary neurotrophic factor |
- |
- |
- |
090 1件: 90 💬 |
33 |
Circadin |
- |
- |
- |
- |
006 3件: 6 , 13, 90 💬 |
34 |
Circadin 2 mg |
- |
- |
- |
- |
090 1件: 90 💬 |
35 |
Circadin 2 mg comprimidos de liberación prolongada |
- |
- |
- |
- |
090 1件: 90 💬 |
36 |
Cns10-npc implantation |
- |
- |
- |
- |
090 1件: 90 💬 |
37 |
Cnto 2476 |
- |
- |
- |
- |
090 1件: 90 💬 |
38 |
Combination product: prp combined magnovision |
- |
- |
- |
- |
090 1件: 90 💬 |
39 |
Compound thrombosis capsule sig: 1.5g/tid |
- |
- |
- |
- |
090 1件: 90 💬 |
40 |
Conditioned medium (cm) |
- |
- |
- |
- |
090 1件: 90 💬 |
41 |
Continuous oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
090 1件: 90 💬 |
42 |
Coqun |
- |
- |
- |
- |
090 1件: 90 💬 |
43 |
Cornstarch |
Starch, corn |
1件: D05297 D05297 💬 |
- |
- |
090 2件: 90, 257 💬 |
44 |
Cornstarch control |
Starch, corn |
1件: D05297 D05297 💬 |
- |
- |
090 1件: 90 💬 |
45 |
Cpk850 |
- |
- |
- |
- |
090 1件: 90 💬 |
46 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
47 |
Cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
48 |
Dac |
- |
- |
- |
- |
013 3件: 13, 90, 301 💬 |
49 |
Dds |
- |
- |
- |
- |
090 1件: 90 💬 |
50 |
Device: blue light-absorbing sunglasses |
- |
- |
- |
- |
090 1件: 90 💬 |
51 |
Device: dexamethasone injection |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
090 1件: 90 💬 |
52 |
Device: medmont darl adapted chromatic (dac) |
- |
- |
- |
- |
090 2件: 90, 301 💬 |
53 |
Device: moncvone electrophysiology |
- |
- |
- |
- |
090 2件: 90, 301 💬 |
54 |
Device: retmap, rm electrode |
- |
- |
- |
- |
090 2件: 90, 301 💬 |
55 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
56 |
Diagnostic test: ocular coherence tomography-angiography (oct-a) |
- |
- |
- |
- |
090 2件: 90, 301 💬 |
57 |
Docosahexaenoic acid |
Doconexent |
- |
- |
- |
006 7件: 6 , 49, 90, 94, 240, 299, 301 💬 |
58 |
Dorzolamide |
Dorzolamide |
2件: D00653 D00653, D07871 D07871 💬 |
CA1 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion 7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
090 1件: 90 💬 |
59 |
Eylea |
- |
- |
- |
- |
090 2件: 90, 166 💬 |
60 |
Fluocinolone |
Fluocinolone |
- |
- |
- |
090 1件: 90 💬 |
61 |
Fluocinolone acetonide |
Fluocinolone |
1件: D01825 D01825 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
090 1件: 90 💬 |
62 |
Ginkgo |
Ginkgo biloba |
- |
- |
- |
006 4件: 6 , 13, 18, 90 💬 |
63 |
Ginkgo biloba |
Ginkgo biloba |
- |
- |
- |
013 3件: 13, 18, 90 💬 |
64 |
Ginkgo biloba pills sig: 300mg/tid |
Ginkgo biloba |
- |
- |
- |
090 1件: 90 💬 |
65 |
Gs030-dp |
- |
- |
- |
- |
090 1件: 90 💬 |
66 |
Hora-pde6b (aav2/5.hpde6b) |
- |
- |
- |
- |
090 1件: 90 💬 |
67 |
Hrpc |
- |
- |
- |
- |
090 1件: 90 💬 |
68 |
Hrpc dp |
- |
- |
- |
- |
090 1件: 90 💬 |
69 |
Human embryonic stem cell derived retinal pigment epithelium (rpe) |
- |
- |
- |
- |
090 1件: 90 💬 |
70 |
Human primary retinal pigment epithelial (hurpe) cells |
- |
- |
- |
- |
090 1件: 90 💬 |
71 |
Human retinal progenitor cells |
- |
- |
- |
- |
090 1件: 90 💬 |
72 |
Human retinal progenitor cells drug product |
- |
- |
- |
- |
090 1件: 90 💬 |
73 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
74 |
Hydroxychloroquine higher dose |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
090 1件: 90 💬 |
75 |
Hydroxychloroquine lower dose |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
090 1件: 90 💬 |
76 |
Iluvien |
- |
- |
- |
- |
090 1件: 90 💬 |
77 |
Intravitreal injection of autologous bone marrow stem cell |
- |
- |
- |
- |
090 1件: 90 💬 |
78 |
Intravitreal injection of autologous bone marrow stem cells |
- |
- |
- |
- |
090 1件: 90 💬 |
79 |
Lentiviral vector containing myo7a gene |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
80 |
Lentiviral vector containing the human my07a gene |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
81 |
Levodopa |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
82 |
Levodopa-carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 2件: 6 , 90 💬 |
83 |
Lutein |
Lutein |
- |
- |
- |
090 2件: 90, 164 💬 |
84 |
Lutein (10 or 30 mg/day) capsules |
Lutein |
- |
- |
- |
090 1件: 90 💬 |
85 |
Lycium barbarum |
- |
- |
- |
- |
090 1件: 90 💬 |
86 |
Melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
87 |
Minocycline |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
002 13件: 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
88 |
N-acetyl cysteine (nac) |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
090 1件: 90 💬 |
89 |
Nac |
- |
- |
- |
- |
034 5件: 34, 51, 85, 90, 299 💬 |
90 |
Nac effervescent tablets |
- |
- |
- |
- |
090 1件: 90 💬 |
91 |
Nerve growt factor - 2.5s |
- |
- |
- |
- |
090 1件: 90 💬 |
92 |
Nerve growth factor |
Nerve Growth Factor |
- |
- |
- |
003 2件: 3 , 90 💬 |
93 |
Nilvadipine |
Nilvadipine |
1件: D01908 D01908 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
94 |
Npi-001 |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
95 |
Nt-501 |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
96 |
Null |
- |
- |
- |
- |
006 16件: 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
97 |
Nutritional supplement |
- |
- |
- |
- |
090 1件: 90 💬 |
98 |
Other: mock injection |
- |
- |
- |
- |
090 1件: 90 💬 |
99 |
Other: observational |
- |
- |
- |
- |
090 1件: 90 💬 |
100 |
Other: sham (no implant) |
- |
- |
- |
- |
090 1件: 90 💬 |
101 |
Other: sham procedure |
- |
- |
- |
- |
090 1件: 90 💬 |
102 |
Other: sham-procedure (dose cohort 1&2 only) |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
103 |
Other: standard of care sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 2件: 90, 301 💬 |
104 |
Other: subconjunctival injection of saline |
- |
- |
- |
- |
090 1件: 90 💬 |
105 |
Other: sugar pill |
- |
- |
- |
- |
090 1件: 90 💬 |
106 |
Other: visual acuity (va) |
- |
- |
- |
- |
090 2件: 90, 301 💬 |
107 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
108 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
109 |
Platelet rich plasma |
- |
- |
- |
- |
046 2件: 46, 90 💬 |
110 |
Procedure: hyperbaric oxygen therapy |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
090 1件: 90 💬 |
111 |
Procedure: sham |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
112 |
Prp |
- |
- |
- |
- |
090 1件: 90 💬 |
113 |
Ps |
- |
- |
- |
- |
046 3件: 46, 90, 97 💬 |
114 |
Qlt091001 |
- |
- |
- |
- |
090 1件: 90 💬 |
115 |
Qr-1123 |
- |
- |
- |
- |
090 1件: 90 💬 |
116 |
Qr-421a |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
117 |
Raav.hpde6a vector |
- |
- |
- |
- |
090 1件: 90 💬 |
118 |
Raav2tyf-grk1-rpgr |
- |
- |
- |
- |
090 1件: 90 💬 |
119 |
Recombinant adeno-associated viral vector serotype 2.7m8 containing the chrimsonr-tdtomato gene |
- |
- |
- |
- |
090 1件: 90 💬 |
120 |
Recombinant human nerve growth factor (rhngf) |
Cenegermin |
1件: D11028 D11028 💬 |
NGFR 1件: NGFR 💬 |
Apoptosis - multiple species 8件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 1件: 90 💬 |
121 |
Retinal pigment epitheliums transplantation |
- |
- |
- |
- |
090 1件: 90 💬 |
122 |
Rhngf |
Cenegermin |
1件: D11028 D11028 💬 |
NGFR 1件: NGFR 💬 |
Apoptosis - multiple species 8件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 1件: 90 💬 |
123 |
Rhngf 180 µg/ml eye drops solution |
Cenegermin |
1件: D11028 D11028 💬 |
NGFR 1件: NGFR 💬 |
Apoptosis - multiple species 8件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 1件: 90 💬 |
124 |
Rhngf 60 µg/ml eye drops solution |
Cenegermin |
1件: D11028 D11028 💬 |
NGFR 1件: NGFR 💬 |
Apoptosis - multiple species 8件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer |
090 1件: 90 💬 |
125 |
Rst-001 |
- |
- |
- |
- |
090 1件: 90 💬 |
126 |
Sar421869 |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
127 |
Sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
128 |
Sodium valproate |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 4件: 2 , 90, 102, 256 💬 |
129 |
Stem cell transplantation |
- |
- |
- |
- |
013 10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
130 |
Stem/progenitor cells transplantation |
- |
- |
- |
- |
090 2件: 90, 301 💬 |
131 |
Subretinal injection of raav.hpde6a |
- |
- |
- |
- |
090 1件: 90 💬 |
132 |
Subretinal injection of umbilical cord blood platelet-rich plasma (cb-prp) |
- |
- |
- |
- |
090 1件: 90 💬 |
133 |
Timrepigene emparvovec |
Timrepigene emparvovec |
- |
- |
- |
090 1件: 90 💬 |
134 |
Tocoferol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
090 1件: 90 💬 |
135 |
Triamcinolone |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬 |
136 |
Twice-daily dosage with 0.5% cyclosporine-a eyedrops |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
137 |
Uf-021 |
- |
- |
- |
- |
090 1件: 90 💬 |
138 |
Uf-021 (isopropyl unoprostone) |
Unoprostone |
1件: D08661 D08661 💬 |
PTGFR 1件: PTGFR 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway |
090 1件: 90 💬 |
139 |
Uf-021(isopropyl unoprostone) |
Unoprostone |
1件: D08661 D08661 💬 |
PTGFR 1件: PTGFR 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway |
090 1件: 90 💬 |
140 |
Umbilical cord mesenchymal stem cell (uc-msc) |
- |
- |
- |
- |
090 1件: 90 💬 |
141 |
Unoprostone |
Unoprostone |
1件: D08661 D08661 💬 |
PTGFR 1件: PTGFR 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway |
090 1件: 90 💬 |
142 |
Ushstat |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
143 |
Ushstat (sar421869) |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
144 |
Va |
- |
- |
- |
- |
090 3件: 90, 301, 302 💬 |
145 |
Valproate |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 6件: 2 , 3 , 90, 102, 233, 256 💬 |
146 |
Valproic acid |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 10件: 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
147 |
Vehicle eye drops |
- |
- |
- |
- |
090 1件: 90 💬 |
148 |
Vitamin a |
Vitamin A |
2件: D00069 D00069, D06543 D06543 💬 |
RARA 2件: RARA, RARB 💬 |
Acute myeloid leukemia 8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
013 3件: 13, 53, 90 💬 |
149 |
Vitamin ad sig: 1 tablet/tid |
- |
- |
- |
- |
090 1件: 90 💬 |
150 |
Vitamin b sig: 10mg/tid |
- |
- |
- |
- |
090 1件: 90 💬 |
151 |
Vitamin e |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
002 11件: 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
152 |
Wharton's jelly derived mesenchymal stem cell |
- |
- |
- |
- |
090 1件: 90 💬 |
153 |
Zuretinol acetate |
Acetate |
- |
- |
- |
090 1件: 90 💬 |